National Procurement process for Extended Half Life Factor IX concentrate has just been completed by the Haemophilia Product Selection and Monitoring Advisory Board (HPSMAB).
The Society are represented on this Board by Declan Noone and Brian O Mahony who is the Vice-Chair of the Board. The contract to be awarded is for a two year term with possible extensions for a third or fourth year at the discretion of the HPSMAB.
The results of the procurement process are announced below in the letter from Dr. Niamh O Connell, Chair of the HPSMAB and Brian O Mahony, Vice-Chair.
